Menzen, Markus

Risk of solid cancer in patients with mast cell activation syndrome: results from Germany and USA

Molderings, G. J., Zienkiewicz, T., Homann, J., Menzen, M., & Afrin, L. B. (2017) · F1000Research

Mast cells and histamineVeterinary Oncology Research

Cited by 38

Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from SemaglUtide Real-world Evidence (SURE) Germany

Menzen, M., Berentzen, T. L., Catarig, A.-M., Pieperhoff, S., Simon, J., & Jacob, S. (2023) · Experimental and Clinical Endocrinology & Diabetes

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 29

Mutational profiling in the peripheral blood leukocytes of patients with systemic mast cell activation syndrome using next-generation sequencing

Altmüller, J., Haenisch, B., Kawalia, A., Menzen, M., Nöthen, M. M., Fier, H., & Molderings, G. J. (2017) · Immunogenetics

Mast cells and histamineCongenital gastrointestinal and neural anomalies

Cited by 14

Glucagon-Like Peptide-1 Receptor Agonist-Experienced Adults with Type 2 Diabetes Switching to Once-Weekly Semaglutide in a Real-World Setting: SURE Program Post Hoc Analysis

Rudofsky, G., Menzen, M., Potier, L., Catarig, A.-M., Clark, A., Priyadarshini, P., & Abreu, C. (2025) · Advances in Therapy

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 3